These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15166928)

  • 1. Role of the tissue factor pathway in the pathogenesis and management of multiple organ failure.
    Smithies MN; Weaver CB
    Blood Coagul Fibrinolysis; 2004 May; 15 Suppl 1():S11-20. PubMed ID: 15166928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis.
    Sungurlu S; Kuppy J; Balk RA
    Crit Care Clin; 2020 Apr; 36(2):255-265. PubMed ID: 32172812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor activity in severe sepsis.
    Creasey AA; Reinhart K
    Crit Care Med; 2001 Jul; 29(7 Suppl):S126-9. PubMed ID: 11445747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
    Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
    Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T
    Crit Care Med; 2001 Jul; 29(7 Suppl):S90-4. PubMed ID: 11445740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulant response in sepsis.
    Levi M
    Clin Chest Med; 2008 Dec; 29(4):627-42, viii. PubMed ID: 18954698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coagulation inhibitors in severe sepsis: state of the art].
    Fourrier F
    Rev Med Interne; 2003 May; 24(5):295-304. PubMed ID: 12763175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sepsis. II. Complications and treatment of sepsis].
    Makovický P; Mokán M; Vladár L; Vrlík M
    Cas Lek Cesk; 1996 Oct; 135(19):614-6. PubMed ID: 8998803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review).
    Jarrar D; Chaudry IH; Wang P
    Int J Mol Med; 1999 Dec; 4(6):575-83. PubMed ID: 10567665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sepsis and organ failure--its pathogenesis and treatment].
    Hanasawa K; Kodama M
    Nihon Geka Gakkai Zasshi; 1998 Aug; 99(8):523-7. PubMed ID: 9789288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple organ dysfunction syndrome.
    Ramírez M
    Curr Probl Pediatr Adolesc Health Care; 2013; 43(10):273-7. PubMed ID: 24295608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sepsis and multiple organ dysfunctions--pathophysiology and the topical concepts of treatment].
    Winter V; Czeslick E; Sablotzki A
    Anesteziol Reanimatol; 2007; (5):66-72. PubMed ID: 18062092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and treatment of organ failure in sepsis.
    Lelubre C; Vincent JL
    Nat Rev Nephrol; 2018 Jul; 14(7):417-427. PubMed ID: 29691495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Critical Care for the Patient with Sepsis and Multiple Organ Dysfunction.
    Kaml GJ; Davis KA
    Anesthesiol Clin; 2016 Dec; 34(4):681-696. PubMed ID: 27816128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dextran-70 on outcome in severe sepsis; a propensity-score matching study.
    Bentzer P; Broman M; Kander T
    Scand J Trauma Resusc Emerg Med; 2017 Jul; 25(1):65. PubMed ID: 28683810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial resuscitation and management of pediatric septic shock.
    Martin K; Weiss SL
    Minerva Pediatr; 2015 Apr; 67(2):141-58. PubMed ID: 25604591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patients with sepsis].
    Oppert M
    Med Klin Intensivmed Notfmed; 2016 May; 111(4):290-4. PubMed ID: 27160262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis.
    Inthorn D; Hoffmann JN; Hartl WH; Mühlbayer D; Jochum M
    Shock; 1998 Aug; 10(2):90-6. PubMed ID: 9721974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome.
    Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
    Crit Care Med; 1997 Nov; 25(11):1820-6. PubMed ID: 9366764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.